China Pharma Debt to Equity Ratio:0.0321 for Dec. 31, 2012
China Pharma Debt to Equity Ratio Chart
China Pharma Historical Debt to Equity Ratio DataPro Data Export
There is no data for the selected date range.
|Data for this Date Range|
|Dec. 31, 2012||0.0321|
|Sept. 30, 2012||0.0265|
|June 30, 2012||0.0267|
|March 31, 2012||0.0271|
|Dec. 31, 2011||0.0276|
|Sept. 30, 2011||0.0288|
|June 30, 2011||0.0295|
|March 31, 2011||0.0307|
|Dec. 31, 2010||0.0321|
|Sept. 30, 2010||0.027|
|June 30, 2010||0.037|
|March 31, 2010||0.0391|
|Dec. 31, 2009||0.0433|
|Sept. 30, 2009||0.0446|
|June 30, 2009||0.0319|
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
CPHI Debt to Equity Ratio Benchmarks
CPHI Debt to Equity Ratio Rankings
1546 of 8009
252 of 687 in Healthcare
16 of 55 in Drug Manufacturers - Major
CPHI Debt to Equity Ratio Range, Past 5 Years
Seeking Alpha May 15
PR Newswire May 15
Seeking Alpha Mar 15